Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitiors of matrix metalloproteinase-1 expression

Cancer Epidemiology

Volumn 36, Issue 6, 2012, Pages

  Hussain, Arif ^a   Harish, Geetganga ^a   Prabhu, Sathyen Alwin ^a   Mohsin, Javeria ^a   Khan, Munawwar Ali ^b   Rizvi, Tahir A ^c   Sharma, Chhavi ^a  

^a Manipal University   (United Arab Emirates)

^b ZAYED UNIVERSITY   (United Arab Emirates)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Apoptosis; Cervical cancer; Chemoprevention; Genistein; Invasion; MMP 9; TIMP 1

Indexed keywords

GELATINASE B; GENISTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DETERMINATION; DOSE RESPONSE; GENE EXPRESSION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL MOVEMENT; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HELA CELLS; HUMANS; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UTERINE CERVICAL NEOPLASMS;

EID: 84868300481     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.07.005     Document Type: Article

References (64)

1. Liu E.H., Qi L.W., Wu Q., Peng Y.B., Li P. Anticancer agents derived from natural products. Mini Reviews in Medicinal Chemistry 2009, 9(13):1547-1555.
2. Huang W.Y., Cai Y.Z., Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutrition and Cancer 2010, 62(1):1-20.
3. Nishiumi S., Miyamoto S., Kawabata K., Ohnishi K., Mukai R., Murakami A., et al. Dietary flavonoids as cancer-preventive and therapeutic biofactors. Frontiers in Bioscience (Scholar Edition) 2011, 3:1332-1362.
4. Pan M.H., Chiou Y.S., Wang Y.J., Ho C.T., Lin J.K. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate. Food & Function 2011, 2(2):101-110.
5. Pereira M.M., Haniadka R., Chacko P.P., Palatty P.L., Baliga M.S. Zingiber officinale Roscoe (ginger) as an adjuvant in cancer treatment: a review. Journal of BUON 2011, 16(3):414-424.
6. Bharti A.C., Aggarwal B.B. Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. Annals of the New York Academy of Sciences 2002, 973:392-395.
7. Fresco P., Borges F., Marques M.P., Diniz C. The anticancer properties of dietary polyphenols and its relation with apoptosis. Current Pharmaceutical Design 2010, 16(1):114-134.
8. Nambiar D., Rajamani P., Singh R.P. Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutation Research 2011, 728(3):139-157.
9. Adlercreutz C.H., Goldin B.R., Gorbach S.L., Hockerstedt K.A., Watanabe S., Hamalainen E.K., et al. Soybean phytoestrogen intake and cancer risk. Journal of Nutrition 1995, 125:757S-770S.
10. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. American Journal of Clinical Nutrition 1998, 68:1333S-1346S.
11. Li Y., Upadhyay S., Bhuiyan M., Sarkar F.H. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999, 18(20):3166-3172.
12. Davis J.N., Muqim N., Bhuiyan M., Kucuk O., Pienta K.J., Sarkar F.H. Inhibition of prostate specific antigen expression by genistein in prostate cancer cells. International Journal of Oncology 2000, 16(6):1091-1097.
13. Alhasan S.A., Aranha O., Sarkar F.H. Genistein elicits pleiotropic molecular effects on head and neck cancer cells. Clinical Cancer Research 2001, 7(12):4174-4181.
14. Sarkar F.H., Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer and Metastasis Reviews 2002, 21:265-280.
15. Chodon D., Ramamurty N., Sakthisekaran D. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line. Toxicol in Vitro 2007, 21(5):887-891.
16. Qi W., Weber C.R., Wasland K., Savkovic S.D. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 2011, 11:219.
17. Kazi A., Daniel K.G., Smith D.M., Kumar N.B., Dou Q.P. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochemical Pharmacology 2003, 66(6):965-976.
18. Deeb D.D., Jiang H., Gao X., Divine G., Dulchavsky S.A., Gautam S.C. Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. Journal of Experimental Therapeutics and Oncology 2005, 581-591.
19. Khan N., Adhami V.M., Mukhtar H. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocrine Related Cancers 2010, 17:R39-R52.
20. Li M., Zhang Z., Hill D.L., Chen X., Wang H., Zhang R. Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Research 2005, 65:8200-8208.
21. Gong L., Li Y., Nedeljkovic-Kurepa A., Sarkar F.H. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003, 22:4702-4709.
22. Wei H., Bowen R., Cai Q., Barnes S., Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proceedings of the Society for Experimental Biology and Medicine 1995, 208(1):124-130.
23. Yuan-Jing F., Nan-Shan H., Lian X. Genistein synergizes with RNA interference inhibiting surviving for inducing DU-145 of prostate cancer cells to apoptosis. Cancer Letters 2009, 284:189-197.
24. Hussain A., Brahmbhatt K., Priyani A., Ahmed M., Rizvi T.A., Sharma C. Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer Biotherapy and Radiopharmaceuticals 2011, 26(5):519-527.
25. Nunez R. DNA measurement and cell cycle analysis by flow cytometry. Current Issues in Molecular Biology 2001, 3(3):67-70.
26. Matsuura N., Miyamae Y., Yamane K., Nagao Y., Hamada Y., Kawaguchi N., et al. Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. Journal of Nutrition 2006, 136:842S-846S.
27. Roeb E., Bosserhoff A.K., Hamacher S., Jansen B., Dahmen J., Wagner S., et al. Enhanced migration of tissue inhibitor of metalloproteinase overexpressing hepatoma cells is attributed to gelatinases: relevance to intracellular signaling pathways. World Journal of Gastroenterology 2005, 11(8):1096-1104.
28. Stoler M.H. Advances in cervical screening technology. Modern Pathology 2000, 13(3):275-284.
29. Shinyo Y., Kodama J., Hongo A., Yoshinouchi M., Hiramatsu Y. Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer. Annals of Oncology 2003, 14(10):1505-1510.
30. Sporn M.B., Suh N. Chemoprevention of cancer. Carcinogenesis 2000, 21(3):525-530.
31. Zhang S., Li L., Lin J.Y., Lin H. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World Journal of Gastroenterology 2003, 9(5):899-904.
32. Tsao A.S., Kim E.S., Hong W.K. Chemoprevention of cancer. CA: A Cancer Journal for Clinicians 2004, 54:150-180.
33. Weng C.J., Yen G.C. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treatment Reviews 2012, 38(1):76-87.
34. Sarkar F.H., Li Y. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacologica Sinica 2007, 28(9):1305-1315.
35. Pavese J.M., Farmer R.L., Bergan R.C. Inhibition of cancer cell invasion and metastasis by genistein. Cancer and Metastasis Reviews 2010, 29(3):465-482.
36. Senft C., Polacin M., Priester M., Seifert V., Kögel D., Weissenberger J. The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer 2010, 10:491.
37. Gupta S., Pramanik D., Mukherjee R., Campbell N.R., Elumalai S., de Wilde R.F., et al. Molecular determinants of retinoic acid sensitivity in pancreatic cancer. Clinical Cancer Research 2012, 18(1):280-289.
38. Yuan J.P., Wang J.H., Liu X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora - implications for health. Molecular Nutrition & Food Research 2007, 51(7):765-781.
39. Hillman G.G., Forman J.D., Kucuk O., Yudelev M., Maughan R.L., Rubio J., et al. Genistein potentiates the radiation effect on prostate carcinoma cells. Clinical Cancer Research 2001, 7:382-390.
40. Hail N., Lotan R. Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state. Molecular Nutrition & Food Research 2009, 53(1):49-67.
41. D'Agostini F., Izzotti A., Balansky R.M., Bennicelli C., De Flora S. Modulation of apoptosis by cancer chemopreventive agents. Mutation Research 2005, 591(1-2):173-186.
42. Roy H.K., Karoski W.J., Ratashak A., Smyrk T.C. Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation. British Journal of Cancer 2001, 84(10):1412-1416.
43. Kim S.H., Kim S.H., Lee S.C., Song Y.S. Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells. Annals of the New York Academy of Sciences 2009, 1171:196-201.
44. Wang S.Y., Yang K.W., Hsu Y.T., Chang C.L., Yang Y.C. The differential inhibitory effects of genistein on the growth of cervical cancer cells in vitro. Neoplasma 2001, 48(3):227-233.
45. Zhou N., Yan Y., Li W., et al. Genistein inhibition of topoisomerase IIα expression participated by Sp1 and Sp3 in HeLa cell. International Journal of Molecular Sciences 2009, 10:3255-3268.
46. Choi Y.H., Zhang L., Lee W.H., Park K.Y. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. International Journal of Oncology 1998, 13(2):391-396.
47. Han H., Zhong C., Zhang X., Liu R., Pan M., Tan L., et al. Genistein induces growth inhibition and G2/M arrest in nasopharyngeal carcinoma cells. Nutrition and Cancer 2010, 62(5):641-647.
48. Zhao R., Xiang N., Domann F.E., Zhong W. Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells. Nutrition and Cancer 2009, 61(3):397-407.
49. Ouyang G., Yao L., Ruan K., Songa G., Mao Y., Bao S. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways. Cell Biology International 2009, 33(12):1237-1244.
50. Gossner G., Choi M., Tan L., Fogoros S., Griffith K.A., Kuenker M., et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecologic Oncology 2007, 105(1):23-30.
51. Kohn E.C., Liotta L.A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Research 1995, 55(9):1856-1862.
52. Sporn M.B. The war on cancer. Lancet 1996, 347(9012):1377-1381.
53. Moiseeva E.P., Almeida G.M., Jones G.D.D., Manson M.M. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Molecular Cancer Therapeutics 2007, 6:3071.
54. Valachovicova T., Slivova V., Bergman H., Shuherk J., Sliva D. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways. International Journal of Oncology 2004, 25(5):1389-1395.
55. Lee W.Y., Huang S.C., Tzeng C.C., Chang T.L., Hsu K.F. Alterations of metastasis-related genes identified using an oligonucleotide microarray of genistein-treated HCC1395 breast cancer cells. Nutrition and Cancer 2007, 58(2):239-246.
56. El Touny L.H., Banerjee P.P. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Research 2009, 69(8):3695-3703.
57. Li Y., Bhuiyan M., Sarkar F.H. Induction of apoptosis and inhibition of c-erb-B in MDA-MB-435 cells by genistein. International Journal of Oncology 1999, 15:525-533.
58. Shao Z.M., Wu J., Shen Z.Z., Barsky S.H. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Research 1998, 58:4851-4857.
59. Ling H., Yang H., Tan S.H., Chui W.K., Chew E.H. 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-κB activation. British Journal of Pharmacology 2010, 161(8):1763-1777.
60. Sartor L., Pezzato E., Dona M., Dell'Aica I., Calabrese F., Morini M., et al. Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model. International Journal of Cancer 2004, 112:823-829.
61. Hong J.H., Ahn K.S., Bae E., Jeon S.S., Choi H.Y. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer and Prostatic Diseases 2006, 9(2):147-152.
62. Kapsoritakis A.N., Kapsoritaki A.I., Davidi I.P., Lotis V.D., Manolakis A.C., Mylonis P.I., et al. Imbalance of tissue inhibitors of metalloproteinases (TIMP)-1 and -4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterology 2008, 8:55.
63. Li Y., Che M., Bhagat S., Ellis K.L., Kucuk O., Doerge D.R., et al. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia 2004, 6:354.
64. Huang X., Chen S., Xu L., Liu Y., Deb D.K., Platanias L.C., et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Research 2005, 65:3470-3478.